SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-20-022153
Filing Date
2020-11-20
Accepted
2020-11-20 18:00:12
Documents
1
Period of Report
2020-11-20

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 32208
  Complete submission text file 0001493152-20-022153.txt   33843
Mailing Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019
Business Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019 646-813-4701
ABEONA THERAPEUTICS INC. (Issuer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4848 LEMMON AVENUE, SUITE 517 DALLAS TX 75219
Business Address
Wider Todd (Reporting) CIK: 0001642715 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-15771 | Film No.: 201333694